Tyropanoate: Difference between revisions
m (Protected "Tyropanoate": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 26: | Line 26: | ||
{{SI}} | {{SI}} | ||
'''Tyropanoic acid''' and its salt '''sodium tyropanoate''' are [[radiopaque]] [[contrast media]] used in [[cholecystography]] ([[X-ray]] diagnosis of [[gallstone]]s). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5611|title=PubChem CID 5611}}</ref> The molecule contains three heavy [[iodine]] atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the [[bile]].<ref>PMID 7364937</ref> | '''Tyropanoic acid''' and its salt '''sodium tyropanoate''' are [[radiopaque]] [[contrast media]] used in [[cholecystography]] ([[X-ray]] diagnosis of [[gallstone]]s). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5611|title=PubChem CID 5611}}</ref> The molecule contains three heavy [[iodine]] atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the [[bile]].<ref>PMID 7364937</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Contrast media}} | {{Contrast media}} | ||
[[Category:Organoiodides]] | [[Category:Organoiodides]] | ||
Latest revision as of 15:40, 6 September 2012
|
WikiDoc Resources for Tyropanoate |
|
Articles |
|---|
|
Most recent articles on Tyropanoate Most cited articles on Tyropanoate |
|
Media |
|
Powerpoint slides on Tyropanoate |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tyropanoate at Clinical Trials.gov Clinical Trials on Tyropanoate at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tyropanoate
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tyropanoate Discussion groups on Tyropanoate Patient Handouts on Tyropanoate Directions to Hospitals Treating Tyropanoate Risk calculators and risk factors for Tyropanoate
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tyropanoate |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Tyropanoic acid and its salt sodium tyropanoate are radiopaque contrast media used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]
References
- ↑ "PubChem CID 5611".
- ↑ PMID 7364937